SkyCell increases availability in U.S. market with new partnership
SkyCell is excited to partner with United to increase the availability of SkyCell containers for the U.S. pharma industry. United and SkyCell share the goal of eliminating temperature excursions and reducing the CO2 footprint in global pharma transportation.
SkyCell is a Swiss-based, award-winning provider of temperature-controlled containers whose highly secure and efficient design features patented insulation and a special rechargeable cooling technology. Each container is equipped with IoT (“internet of things”) sensors that connect to SkyCell’s cloud-based, blockchain-encrypted software. These sensors monitor temperature, humidity and other factors to ensure the best possible protection against excursions.
SkyCell’s creative use of technology enables them to offer safe and highly reliable logistics services for biopharmaceuticals and other products sensitive to even slight changes in temperature. A recent year-long external audit found temperature excursions in a scant .01 percent of shipments transported in SkyCell’s containers.
TempControl’s transport of vaccines and other high-value biopharmaceutical shipments is increasing rapidly. Extremely precise, long-duration temperature control is required for the safe transport of these highly sensitive shipments. That’s why we’re very excited to launch this partnership. Combining the proven reliability and high performance of SkyCell’s containers with TempControl’s extensive network and relentless focus on control and integrity creates the level of quality service today’s health care shippers demand.